Resources
- Press Releases
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE)...
- Press Releases
Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data...
- Blogs
By Peter Neumann Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center;...
- Blogs
By Meg Richards, PhD, MPH, Executive Director of Solutions, Panalgo
- Articles
By Meg Richards, PhD, MPH, Executive Director, Scientific Strategy at Panalgo, with Andrew Goldstein, VP of Client Partnerships at Panalgo
- Blogs
Three Key Themes from Panalgo’s Data to Insights 2024 Conference
- Press Releases
[Boston, May 1, 2024] – Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, announced today its partnership with Truveta, the company with a...
Panalgo Partners with COTA, Adding Oncology Data to Its Industry-Leading IHD Platform
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings clarity to cancer care with
Panalgo Introduces IHD Cloud, a Transformative Solution for RWE Data and Analytics Centralization
Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations
Treatment of Anxiety and Depression in Pregnancy – What do the Data Tell Us?
Treating anxiety and depression during pregnancy is a complex and crucial aspect of maternal healthcare. There are extensive data available on the safety of anti-anxiety
Emerging Issues in Real-World Evidence: How Observational Studies Can Complement Randomized Controlled Trials
The randomized controlled trial (RCT) forms the cornerstone of drug approval by regulatory agencies, providing robust evidence on the safety and efficacy of new therapies.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization